Catheter-associated bloodstream infections in pediatric hematology-oncology patients: Factors associated with catheter removal and recurrence

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 1, 2006, Pages 23-28

  Adler, Amos ^a,c,d   Yaniv, Isaac ^a,c   Solter, Ester ^a,c   Freud, Enrique ^a,c   Samra, Zmira ^b,c   Stein, Jerry ^a,c   Fisher, Salvador ^a,c   Levy, Itzhak ^a,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Catheter removal; Catheter associated bloodstream infection; Hickman; Implantable ports; Recurrence

Indexed keywords

ANTIBIOTIC AGENT;

ANALYTIC METHOD; BACTEREMIA; BACTERIUM ISOLATION; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; EMPIRICISM; FEMALE; HUMAN; HYPOTENSION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SEPSIS; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; ADOLESCENT; ADULT; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INDWELLING CATHETER; INFANT; MICROBIOLOGY; NEOPLASM; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; BACTEREMIA; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 33644842193     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1080/10910340500534282     Document Type: Review

References (22)

1. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol. 1992;10:1943-1948.
2. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991;13:130-136.
3. Mirro J Jr, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg. 1990;25:120-124.
4. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child. 1988;142:536-540.
5. Flynn PM, Willis B, Gaur AH, et al. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol. 2003;21:3520-3525.
6. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2002;35:1281-1307.
7. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
8. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
9. National Committee for Clinical Laboratory Standards. Improved Standards Ms. A3. Villanova, PA: National Committee for Clinical Laboratory Standards, 1984.
10. Rubin LG, Shih S, Shende A, et al. Cure of implantable port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis. 1999;29:102-105.
11. Sotir MJ, Lewis C, Bisher EW, et al. Epidemiology of device-associated infections related to long-term implantable vascular access device. Infect Control Hosp Epidemiol. 1999;20:187-191.
12. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients. Cancer. 1997;79:1635-1640.
13. Elishoov H, Or R, Strauss N, et al. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients: a 5-year prospective study. Medicine. 1998;77:83-101.
14. Yuen KY, Woo PCY, Hui CH, et al. Unique risk factors for bacteremia in allogeneic bone marrow transplant recipient before and after engraftment. Bone Marrow Transplant. 1998;21:1137-1143.
15. Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol. 1995;16:451-458.
16. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4:481-489.
17. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis. 1991;163:951-958.
18. Ramphal R, Bolger M, Oblon DJ, et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrob Agents Chemother. 1992;36:1062-1067.
19. Engelhard D, Elishoov H, Strauss N, et al. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation. 1996;61:430-434.
20. Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003;41:3655-3660.
21. Van de Wetering MD, Poole J, Friedland I, et al. Bacteremia in pediatric oncology unit in South Africa. Med Pediatr Oncol. 2001;37:525-531.
22. Blot F, Nitenberg G, Brun-Buisson C. New tools in diagnosing catheter-related infections. Support Care Cancer. 2000;8:287-292.